SEARCH

SEARCH BY CITATION

reference

  • 1
    Hosenpud, JD, Bennett, LE, Keck, BM, Boucek, MM, Novick, RJ (2001) The Registry of the International Society for Heart and Lung Transplantation: 18th Official Report 2001. J Heart Lung Transplant 20:805.
  • 2
    Reid, KR, Menkis, AH, Novick, RJ, et al. (1991) Reduced incidence of severe infection after heart transplantation with low-intensity immunosuppression. J Heart Lung Transplant 10:894.
  • 3
    Swinnen, LJ, Costanzo-Nordin, MR, Fisher, SG, et al. (1990) Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med 323:1723.
  • 4
    Kobashigawa, JA, Kirklin, JK, Naftel, DC, et al. (1993) Pretransplantation risk factors for acute rejection after heart transplantation: a multi-institutional study. J Heart Lung Transplant 12:355.
  • 5
    Kirklin, JK, Naftel, DC, Bourge, RC, et al. (1992) Rejection after cardiac transplantation. A time-related risk factor analysis. Circulation 86 [suppl 11]:236.
  • 6
    Stinson, EB, Dong, E Jr, Iben, AB, Shumway, EN (1969) Cardiac transplantation in man: III. Surgical aspects. Am J Surg 118:182.
  • 7
    Billingham, ME, Cary, NRB, Path, MRC, et al. (1990) A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Transplant 9:587.
  • 8
    Kobashigawa, JA, Miller, L, Young, A, et al. (1995) Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound. J Heart Lung Transplant 14:S221.
  • 9
    Miller, L, Kobashigawa, J, Hauptman, P, et al. (1996) Definition of critical cyclosporine level for preventing rejection in heart transplant patients. J Heart Lung Transplant 15:S77.
  • 10
    El Gamel, A, Keevil, B, Rahman, A, et al. (1997) Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection. J Heart Lung Transplant 16:268.
  • 11
    Hausen, B, Demertzis, S, Rohde, R, et al. (1994) Low-dose cyclosporine therapy in triple drug immunosuppression for heart transplant recipients. Ann Thorac Surg 58:999.
  • 12
    Kelly, JJ, Walker, RG, D'Apice, AJF, et al. (1990) A prospective study of the effect of diltiazem in renal allograft recipients receiving cyclosporin A: preliminary results. Transplant Proc 22:2127.
  • 13
    Schroeder, JS, Gao, SZ, Alderman, EL, et al. (1993) A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med 328:164.
  • 14
    Kunzendorf, U, Walz, G, Brockmöller, J, et al. (1991) Effects of diltiazem upon metabolism and immunosuppressive action of cyclosporine in kidney graft recipients. Transplantation 52:280.
  • 15
    Mies, S, Massarollo, PCB, Figueira, ERR, et al. (1998) Lower incidence of liver graft rejection in patients on diltiazem plus cyclosporine therapy. Transplant Proc 30:1347.
  • 16
    Dumont, L, Chen, H, Daloze, P, et al. (1993) Immunosuppressive properties of the benzothiazepine calcium antagonists diltiazem and clentiazem, with and without cyclosporine, in heterotopic rat heart transplantation. Transplantation 56:181.
  • 17
    Libersan, D, Marchand, R, Montplaisir, S, et al. (1997) Cardioprotective effects of diltiazem during acute rejection on heterotopic heart transplants. Eur Surg Res 29:229.
  • 18
    Lapointe, N, Chen, H, Qi, S, et al. (1999) Immunomodulating effects of second-generation calcium channel blockers on experimental heart transplantation. Eur Surg Res 31:259.
  • 19
    Brckmöller, J, Neumayer, HH, Wagner, K, et al. (1990) Pharmacokinetic interaction between cyclosporine and diltiazem. Eur J Clin Pharmacol 38:237